MENU
SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis
a developer of novel gene therapy platform for advancing disease
Industry Biotechnology
Show more...
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I. Advisor
published General Information
General Information
a developer of novel gene therapy platform for advancing disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
88
Web
https://www.solidbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLSRX | 6.43 | 0.03 | +0.47% |
| abrdn Focused U.S. Small Cap Eq R | |||
| SJGAX | 29.47 | N/A | N/A |
| Steward Large Cap Growth A | |||
| JEPRX | 13.98 | -0.01 | -0.07% |
| JPMorgan Equity Premium Income R6 | |||
| KLCIX | 21.98 | -0.13 | -0.59% |
| Federated Hermes Kaufmann Large Cap IS | |||
| VEUVX | 33.30 | -0.21 | -0.63% |
| JPMorgan Europe Dynamic R6 | |||
SLDB and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SLDB | 1D Price Change % | ||
|---|---|---|---|---|
| SLDB | 100% | +2.38% | ||
| ACLX - SLDB | 43% Loosely correlated | +0.95% | ||
| ATHE - SLDB | 39% Loosely correlated | +0.31% | ||
| BBIO - SLDB | 37% Loosely correlated | +1.29% | ||
| FULC - SLDB | 36% Loosely correlated | +0.93% | ||
| VRDN - SLDB | 36% Loosely correlated | +3.29% | ||
More | ||||